Biochemistry
Global

Biochemistry Experts

Paul Feldman

Head of Discovery and Translational Medicine
organic chemistry
Intarcia Therapeutics
United States of America

Paul Feldman

Biography

 Dr. Paul Feldman joined Intarcia in September 2015 as Head of Discovery and Translational Medicine. Dr. Feldman assumed this new role following Intarcia’s acquisition of Phoundry Pharmaceuticals, Inc., a peptide therapeutic discovery company, where he was a co-founder and CEO. Prior to his work at Phoundry, Dr. Feldman worked for GlaxoSmithKline, ultimately as a senior vice president, and some of his accomplishments included: contributing to the discovery and development of multiple medicines, leading national and international multi-disciplinary discovery and early development groups, managing several key multi-national business collaborations, and serving as the head for GlaxoSmithKline’s Research Triangle Park site. Dr. Feldman has more than 100 scientific disclosures (patents, scientific articles, book chapters, and invited lectures), and has been an adjunct Professor of Chemistry for Duke and North Carolina State Universities. 

Research Interest

 He has served in multiple leadership roles for the executive committee of the Division of Organic Chemistry of the American Chemical Society, and is currently an editor for “Organic Reactions”. He received a B.S in chemistry from Duke University and a Ph.D. in organic chemistry from the University of California, Berkeley.

Global Experts from United States of America

Global Experts in Subject

Share This Profile
Recommended Journals
View more
Recommended Conferences
  • 12thInternational Conference on Advancements in Bioinformatics and Drug Discovery November 26-27, 2018 Dublin, Ireland.

    November 26-27, 2018 Dublin, Ireland

  • 12th International Conference and Expo on Proteomics and Molecular Medicine

    November 26-28, 2018 Dublin, Ireland

  • 4th International Conference on Genetic and Protein Engineering December 05-06, 2018 Chicago, USA

    ,

View more
Relevant Topics